Sartorius Ag (SARTF) Cut to “Sell” at Zacks Investment Research
Sartorius Ag (NASDAQ:SARTF) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Wednesday.
According to Zacks, “Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. “
Separately, DZ Bank AG restated a “sell” rating on shares of Sartorius Ag in a report on Friday, July 21st.
Shares of Sartorius Ag (NASDAQ SARTF) traded up 0.0000% during mid-day trading on Wednesday, reaching $94.0688. The company has a market cap of $6.43 billion and a P/E ratio of 52.0004. Sartorius Ag has a one year low of $75.00 and a one year high of $96.00.
WARNING: “Sartorius Ag (SARTF) Cut to “Sell” at Zacks Investment Research” was first published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States & international copyright & trademark laws. The original version of this piece can be accessed at https://www.americanbankingnews.com/2017/10/15/sartorius-ag-sartf-cut-to-sell-at-zacks-investment-research.html.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sartorius Ag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius Ag and related companies with MarketBeat.com's FREE daily email newsletter.